Neuralstem Inc (NYSE MKT LLC:CUR)

Data as of Jan 23
 -0.01 / -0.32%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Neuralstem, Inc. is a biopharmaceutical company, which is focused on the development and commercialization of treatments based on human neuronal stem cells and small molecule compounds. It develops biotherapeutic products to treat and cure neurodegenerative and neurological disorders of the brain and spinal cord, including Parkinson's, Alzheimer's, stroke, multiple sclerosis, spinal cord injury and epilepsy. The company was founded by I. Richard Garr, Karl Johe and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

Contact Information

Neuralstem, Inc.
20271 Goldenrod Lane
Germantown Maryland 20876
P:(301) 366-4960
Investor Relations:



Individual stakeholders6.26%
Other institutional5.76%
Mutual fund holders14.29%

Top Executives

Karl Y. JoheChairman & Chief Scientific Officer
I. Richard GarrPresident, CEO, CFO, Director & Legal Counsel
Thomas G. HazelSenior Vice President-Research

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.